TSPO (Translocator Protein) is a conserved membrane protein located on the outer mitochondrial membrane of eukaryotic cells, with the 18 kDa subtype being the most studied in mammals. It regulates steroid synthesis, mitochondrial function, apoptosis, and immune responses, influencing mitochondrial membrane permeability, energy metabolism, and cellular stress through pathways such as PKA, MAPK, and NF-κB. TSPO plays a significant role in neurodegenerative diseases (e.g., Alzheimer's, Parkinson's), psychiatric disorders (e.g., anxiety, depression), cancer, and inflammatory diseases, with its altered expression making it a potential target for diagnosis and therapy[1].
Kv7.2/Kv7.3 activator-3 (GRT-X) 是一种具有口服活性的 Kv7.2/Kv7.3 和 TSPO 激活剂,可激活 Kv7.2/Kv7.3、Kv7.4 和 Kv7.5(EC50 分别为 0.37、2.06 和 0.75 μM)并结合 TSPO(Ki 分别为 0.07 μM(大鼠膜)和 4.60 μM(人 U-118 MG 细胞)),能防止小鼠和人类肌萎缩侧索硬化症/额颞叶痴呆星形胶质细胞条件培养基暴露后运动神经元的变性,通过 TSPO 和 Kv7.2/3 激活刺激背根神经节轴突生长,在癫痫发作模型中具有抗癫痫功效,并可减轻糖尿病神经病变患者的痛觉过敏、促进大鼠颈神经病变后神经元的存活和再生、加速感觉神经元和运动神经元的正常功能恢复。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号